In accordance with our in silico analysis of clinical NSCLCs, mRNA levels of TBX4 and TBX5 exhibited more pronounced suppression in NSCLC cell lines, particularly when cells were cultured in reduced serum conditions, compared with levels of TBX2 and TBX3 (Figure 3). The gene discussed is TBX5; the disease is non-small cell lung carcinoma.